AstraZeneca PLC
Explore AstraZeneca
Core profile pages, annual revenue records, and related research hubs for this company.
AstraZeneca PLC
Explore AstraZeneca
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$58.7B
Market Cap
$275.0B
Net Income
$10.2B
Employees
89,900
AstraZeneca reported FY2025 total revenue of $58.739B, up 9% at actual exchange rates, and profit for the year of $10.233B. Growth was driven by oncology, cardiovascular, renal and metabolism, respiratory and immunology, and rare disease medicines. The strategic questions are pipeline productivity, patent exposure, China and U.S. policy risk, and execution toward the company's 2030 revenue ambitions.
Revenue Trend Analysis
YoY Change
+8.6%
2-Year CAGR
+13.2%
Peak Year
2025
Trend
Consistent Growth
AstraZeneca PLC has reported revenue across 3 fiscal years, compounding at +13.2% annually over 2 years. The most recent year saw a 8.6% increase versus the prior year. Revenue peaked in 2025 at $58.7B. Out of 2 reported periods, 2 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $58.7B | $10.2B | +8.6% |
| FY2024 | $54.1B | — | +18.0% |
| FY2023 | $45.8B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
AstraZeneca reported $58.7B in FY2025 total revenue and $10.2B in profit for the year.
Yes, with specialty margins supported by patented product mix.
AstraZeneca reported approximately 89,900 employees in FY2025.
The AstraZeneca financials page lists annual revenue history and segment context.
AstraZeneca cited growth across oncology, CVRM, respiratory and immunology, and rare disease as drivers of FY2025 total revenue.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "AstraZeneca PLC Revenue & Financials." CorpDigest, https://corpdigest.com/company/astrazeneca/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>AstraZeneca PLC reported $59B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/astrazeneca/financials" target="_blank" rel="noopener">CorpDigest — AstraZeneca PLC financials</a></div>